The lone clinical study gave 12 people with chronic knee pain received an injection, and 7 said they felt better for at least six months But with no control group, no imaging, no diagnosis clarity, and no standardized outcome measure, we cant say the peptide made the difference
My passion is helping people finally get real, lasting reliefwithout feeling like their only options are more medications, more injections, or surgery
Metformin, a known activator of AMPK and a first-line pharmacological therapy for type II diabetes mellitus, has been tested as an immunomodulator in SLE [25,91], but more definitive data are needed to gauge the potential role of targeting AMPK in treating SLE patients
Godard MP, Johnson BA, Richmond SR